APA (7th ed.) Citation

Steinbild, S., Mros, K., Frost, A., Morant, R., Gillessen, S., Dittrich, C., . . . Mross, K. (2007). A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: A study of the CESAR Central European Society for Anticancer Drug Research-EWIV. British Journal of Cancer, 97(11), 1480. https://doi.org/10.1038/sj.bjc.6604064

Chicago Style (17th ed.) Citation

Steinbild, S., et al. "A Clinical Phase II Study with Sorafenib in Patients with Progressive Hormone-refractory Prostate Cancer: A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV." British Journal of Cancer 97, no. 11 (2007): 1480. https://doi.org/10.1038/sj.bjc.6604064.

MLA (9th ed.) Citation

Steinbild, S., et al. "A Clinical Phase II Study with Sorafenib in Patients with Progressive Hormone-refractory Prostate Cancer: A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV." British Journal of Cancer, vol. 97, no. 11, 2007, p. 1480, https://doi.org/10.1038/sj.bjc.6604064.